Exercise Remains Crucial Alongside GLP-1 Obesity Drugs, Experts and Studies Suggest

Written By :  Anshika Mishra
Published On 2026-05-08 02:30 GMT   |   Update On 2026-05-08 09:43 GMT
Advertisement

Weight-loss drugs may be changing obesity treatment, but they are not replacing one of medicine's most powerful tools: movement. A new perspective published in the Journal of the American Medical Association argues that exercise remains essential—even in the era of popular GLP-1 medications.

The article explores a growing concern in obesity care: many patients lose weight with GLP-1 therapies, but struggle to maintain muscle mass and long-term results without physical activity.

GLP-1 drugs work largely by reducing appetite and calorie intake—sometimes by nearly 40%—leading to substantial weight loss. However, researchers warn that a significant portion of this weight loss can come from fat-free mass, including muscle. This raises the risk of sarcopenia, or age-related muscle loss, which can weaken strength, mobility, and metabolic health over time.

Exercise offers benefits that medication alone cannot fully replace. Physical activity improves insulin sensitivity, increases fat burning, supports cardiovascular health, and most importantly, helps preserve muscle during weight loss. It also plays a major role in preventing weight regain, especially since studies show up to 60% of patients stop taking GLP-1 medications within a year.

The challenge is adherence. Many people find exercise difficult to sustain due to a lack of time, physical discomfort, limited access to facilities, or simply because it feels unrewarding. The authors argue that clinicians should move beyond generic advice like “exercise more” and instead help patients build realistic, personalized movement routines they can actually maintain.

In the evolving landscape of obesity treatment, the message is clear: medications may accelerate weight loss, but sustainable health still depends heavily on staying active.

REFERENCE: Lieberman, D.E., (2026). The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era. JAMA. DOI: 10.1001/jama.2026.5537. https://jamanetwork.com/journals/jama/article-abstract/2848640

Full View
Tags:    
Article Source : JAMA

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News